CLOSED STUDIES / Ovarian Cancer


ENGOT – OV-2b / TRINOVA 3 /GEICO-1201


Title

TRINOVA – A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers.


GEICO Coordinator

Dr. José María del Campo – Hospital Universitario Vall d’ Hebron


GEICO Investigators

Dr. José María Del Campo. Hospital Universitario Vall d’Hebron.
Dra. Margarita Romeo. Hospital Universitario Germans Trias i Pujol.
Dr. Antonio González. C.O. MD Anderson Internacional.
Dr. José A. Arranz. Hospital General Universitario Gregorio Marañón.
Dr. Andres Redondo. Hospital Universitario La Paz.
Dra. Ana Santaballa. Hospital Universitario Politécnico La Fe.
Dr. Andres Poveda. IVO.
Dra. Ana Herrero. Hospital Universitario Miguel Servet.
Dra. Isabel Palacio. Hospital Central de Asturias.
Dra. Isabel Bover. Hospital Son Llatzer.
Dra. Eugenia Ortega. Hospital Arnau de Vilanova.
Dra. Eva Guerra. Hospital Ramón y Cajal.
Dr. Antonio Casado. Hospital Clínico San Carlos.


Patients Recruited:

97


Inclusion Closing Date:

March of 2014


Current State:

Following